Skip to main content
. 2022 Feb 18;2022:4709300. doi: 10.1155/2022/4709300

Table 1.

The prevalence of NAFLD decreased with the increase of APOA1 level.

APOA1 levels Total patients Patients with NAFLD Prevalence rate χ2 value P value
Q1 3300 1075 32.58% 292.109 <0.001
Q2 3165 893 28.21%
Q3 3156 680 21.55%
Q4 3202 499 15.58%